Lam Research Corporation vs Vital Farms Inc — how do they compare? Lam Research Corporation trades at $318.84 (market cap $401.19B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Lam Research Corporation is far larger — about 989.9× Vital Farms Inc's market cap, and Lam Research Corporation pays a 0.41% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lam Research Corporation for 60 Days and Vital Farms Inc for 14 Days on average.
| LRCX | VITL | |
|---|---|---|
Market Cap | $401.19B | $405.27M |
Volume | 8,960,892 | 1,810,837 |
Sector | Technology | Consumer Staples |
52-Week High | $433.33 | $43.40 |
52-Week Low | $131.37 | $8.28 |
Typical Hold Time | 60 Days | 14 Days |
Enterprise Value | $399.35B | $492.28M |
Dividend Yield | 0.41% | — |
Signals from Pluang's Aura AI — not financial advice
Lam Research (LRCX) trades at $320.59, down 2.71% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $2.18. Revenue grew to $18.44B in 2025, with a net income margin of 31.27%, while valuation ratios like P/E of 55.66 and P/S of 17.4 reflect high growth expectations. Analyst consensus is strongly bullish with a $375.68 price target, supported by AI-driven demand for semiconductor equipment.
The outlook for LRCX is positive due to robust earnings growth and strategic positioning in AI infrastructure, though risks include high valuation multiples and semiconductor cycle volatility. Upside potential exists if the company meets Q3 2026 earnings expectations and maintains margin expansion, but investors should monitor competitive pressures and macroeconomic factors affecting tech spending.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and negative cash flows. The stock exhibits a bearish technical trend with support near $9 and resistance at $10, while fundamentals show revenue stability but collapsing profitability, with net income margin at 0.02% in 2026. Recent news highlights potential strategic options, including a sale, as the company navigates egg pricing pressure.
The outlook is mixed: analyst consensus is bullish with a $13.11 price target, but near-term risks from industry oversupply and weak margins persist. Upside hinges on execution of strategic reviews and margin recovery, while downside exposure includes sustained cash burn and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →